PRILIGY dapoxetine 30 mg (as hydrochloride) film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

priligy dapoxetine 30 mg (as hydrochloride) film-coated tablet blister pack

a menarini australia pty ltd - dapoxetine hydrochloride, quantity: 33.6 mg (equivalent: dapoxetine, qty 30 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; titanium dioxide; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; iron oxide yellow; microcrystalline cellulose; hypromellose; triacetin; iron oxide black - priligy is indicated for the treatment of premature ejaculation (pe) in men 18 to 64 years of age, who have all of the following: an intravaginal ejaculatory latency time (ielt) of less than two minutes; and persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and marked personal distress or interpersonal difficulty as a consequence of pe; and poor control over ejaculation.

Plotis 30 mg film-coated tablets Malta - English - Medicines Authority

plotis 30 mg film-coated tablets

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - dapoxetine - film-coated tablet - dapoxetine 30 mg - urologicals

Plotis 60 mg film-coated tablets Malta - English - Medicines Authority

plotis 60 mg film-coated tablets

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - dapoxetine - film-coated tablet - dapoxetine 60 mg - urologicals

D-LAST 30 Tablet Kenya - English - Pharmacy and Poisons Board

d-last 30 tablet

dapoxetin hydrochloride - tablet - dapoxetin hydrochloride 30 mg - dapoxetine